157 related articles for article (PubMed ID: 31095199)
1. [Clinical impact of ertapenem de-escalation in critically-ill patients with Enterobacteriaceae infections].
Cuesta DP; Blanco VM; Vallejo ME; Hernández-Gómez C; Maya JJ; Motoa G; Correa A; Matta L; Rosso F; Camargo RD; Muñoz M; Florez E; Nagles J; Ovalle A; Reyes S; Villegas MV
Rev Chilena Infectol; 2019 Feb; 36(1):9-15. PubMed ID: 31095199
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of de-escalation therapy to ertapenem for treatment of infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae: an open-label randomized controlled trial.
Rattanaumpawan P; Werarak P; Jitmuang A; Kiratisin P; Thamlikitkul V
BMC Infect Dis; 2017 Mar; 17(1):183. PubMed ID: 28249572
[TBL] [Abstract][Full Text] [Related]
3. Ertapenem Versus Meropenem for the Treatment of Extended Spectrum Beta-Lactamase-Producing Enterobacterales Bacteremia in Critically Ill Patients.
VanDorf S; Shah P; Yost CN
Ann Pharmacother; 2024 Jul; 58(7):690-697. PubMed ID: 37881901
[TBL] [Abstract][Full Text] [Related]
4. Impact of De-escalation on Prognosis of Patients With Bacteremia due to Enterobacteriaceae: A Post Hoc Analysis From a Multicenter Prospective Cohort.
Palacios-Baena ZR; Delgado-Valverde M; Valiente Méndez A; Almirante B; Gómez-Zorrilla S; Borrell N; Corzo JE; Gurguí M; De la Calle C; García-Álvarez L; Ramos L; Gozalo M; Morosini MI; Molina J; Causse M; Pascual Á; Rodríguez-Baño J;
Clin Infect Dis; 2019 Aug; 69(6):956-962. PubMed ID: 30535051
[TBL] [Abstract][Full Text] [Related]
5. Impact of a restrictive antibiotic policy on the acquisition of extended-spectrum beta-lactamase-producing Enterobacteriaceae in an endemic region: a before-and-after, propensity-matched cohort study in a Caribbean intensive care unit.
Le Terrier C; Vinetti M; Bonjean P; Richard R; Jarrige B; Pons B; Madeux B; Piednoir P; Ardisson F; Elie E; Martino F; Valette M; Ollier E; Breurec S; Carles M; Thiéry G
Crit Care; 2021 Jul; 25(1):261. PubMed ID: 34311760
[TBL] [Abstract][Full Text] [Related]
6. The association between colonization with carbapenemase-producing enterobacteriaceae and overall ICU mortality: an observational cohort study.
Dautzenberg MJ; Wekesa AN; Gniadkowski M; Antoniadou A; Giamarellou H; Petrikkos GL; Skiada A; Brun-Buisson C; Bonten MJ; Derde LP;
Crit Care Med; 2015 Jun; 43(6):1170-7. PubMed ID: 25882764
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the potential impact of a carbapenem de-escalation program in an academic healthcare system.
Ahmad F; Pogue JM; Marchaim D; Chopra T; Bheemreddy S; Lee J; Mudegowdra NS; Chaudhry A; Kaye KS
J Infect Public Health; 2014 Feb; 7(1):50-3. PubMed ID: 24210246
[TBL] [Abstract][Full Text] [Related]
8. Use of non-carbapenem antibiotics to treat severe extended-spectrum β-lactamase-producing Enterobacteriaceae infections in intensive care unit patients.
Luyt CE; Faure M; Bonnet I; Besset S; Huang F; Junot H; Hékimian G; Schmidt M; Bréchot N; Combes A; Aubry A; Mayaux J; Chastre J
Int J Antimicrob Agents; 2019 May; 53(5):547-552. PubMed ID: 30742956
[TBL] [Abstract][Full Text] [Related]
9. Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational study.
Alvarez-Lerma F; Alvarez B; Luque P; Ruiz F; Dominguez-Roldan JM; Quintana E; Sanz-Rodriguez C;
Crit Care; 2006; 10(3):R78. PubMed ID: 16704742
[TBL] [Abstract][Full Text] [Related]
10. De-Escalation of Antibiotics Does Not Increase Mortality in Critically Ill Surgical Patients.
Turza KC; Politano AD; Rosenberger LH; Riccio LM; McLeod M; Sawyer RG
Surg Infect (Larchmt); 2016 Feb; 17(1):48-52. PubMed ID: 26714235
[TBL] [Abstract][Full Text] [Related]
11. Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance in ICU patients: a retrospective observational study.
De Bus L; Denys W; Catteeuw J; Gadeyne B; Vermeulen K; Boelens J; Claeys G; De Waele JJ; Decruyenaere J; Depuydt PO
Intensive Care Med; 2016 Jun; 42(6):1029-39. PubMed ID: 27025939
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and outcomes of anti-infective de-escalation during health care-associated intra-abdominal infections.
Montravers P; Augustin P; Grall N; Desmard M; Allou N; Marmuse JP; Guglielminotti J
Crit Care; 2016 Apr; 20():83. PubMed ID: 27052675
[TBL] [Abstract][Full Text] [Related]
13. De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study.
Mokart D; Slehofer G; Lambert J; Sannini A; Chow-Chine L; Brun JP; Berger P; Duran S; Faucher M; Blache JL; Saillard C; Vey N; Leone M
Intensive Care Med; 2014 Jan; 40(1):41-9. PubMed ID: 24231857
[TBL] [Abstract][Full Text] [Related]
14. A retrospective study of antibiotic de-escalation in patients with ventilator-associated pneumonia in Malaysia.
Khan RA; Aziz Z
Int J Clin Pharm; 2017 Aug; 39(4):906-912. PubMed ID: 28643112
[TBL] [Abstract][Full Text] [Related]
15. Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum β-lactamase urinary tract infections.
Veve MP; Wagner JL; Kenney RM; Grunwald JL; Davis SL
Int J Antimicrob Agents; 2016 Jul; 48(1):56-60. PubMed ID: 27234673
[TBL] [Abstract][Full Text] [Related]
16. Targeted simplification versus antipseudomonal broad-spectrum beta-lactams in patients with bloodstream infections due to
López-Cortés LE; Rosso-Fernández C; Núñez-Núñez M; Lavín-Alconero L; Bravo-Ferrer J; Barriga Á; Delgado M; Lupión C; Retamar P; Rodríguez-Baño J;
BMJ Open; 2017 Jun; 7(6):e015439. PubMed ID: 28601833
[TBL] [Abstract][Full Text] [Related]
17. A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study.
Vasudevan A; Mukhopadhyay A; Li J; Yuen EG; Tambyah PA
BMC Infect Dis; 2014 Nov; 14():615. PubMed ID: 25420613
[TBL] [Abstract][Full Text] [Related]
18. Ertapenem-resistant Enterobacteriaceae: risk factors for acquisition and outcomes.
Hyle EP; Ferraro MJ; Silver M; Lee H; Hooper DC
Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1242-9. PubMed ID: 21029005
[TBL] [Abstract][Full Text] [Related]
19. Collaborative approach of individual participant data of prospective studies of de-escalation in non-immunosuppressed critically ill patients with sepsis.
Gutiérrez-Pizarraya A; Leone M; Garnacho-Montero J; Martin C; Martin-Loeches I
Expert Rev Clin Pharmacol; 2017 Apr; 10(4):457-465. PubMed ID: 28266901
[TBL] [Abstract][Full Text] [Related]
20. Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) infections: are carbapenem alternatives achievable in daily practice?
Pilmis B; Delory T; Groh M; Weiss E; Emirian A; Lecuyer H; Lesprit P; Zahar JR
Int J Infect Dis; 2015 Oct; 39():62-7. PubMed ID: 26327124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
